Hmmm. One word comes to mind about this deal - Suckers! Lots of debt to write-off, declining Biosite business, 4th Gen Rapid that is in future trouble in the public health space because it doesn't detect p24 in Whole Blood and rep turnover. Hope Abt can turn it around on the new Alere-i instrument.
Want in on those big gaining Nasdaq and nyse stocks you see at the top of yahoo every day before they take off? Join ULTIMATE STOCK ALERTS (google em) today. They have nailed their last few momentum calls.
The 2014 year end balance for Alere looks like it needs a good cleaning and looks like a couple billion of debt also goes along with the purchase. Once they get the balance sheet cleaned up it looks like it will be a good deal for Abbott. All cash deal no shareholder dilution.
ULTIMATE STOCK ALERTS (search them) is my edge in the markets. Their plays are all nyse/Nasdaq and the momentum alerts they send out move pretty big. Don’t miss the next alert.
Want a winner? Check out ultimatestockalerts (search em) if you are looking for small cap stocks
before the big run. He has alerted me to a bunch of stocks before they took off.
P/E does not help if you net income and sales are slowing. there are companies with PE of 2. Projected PE is what matters.
My concern is are they using a strong dollar as an excuse for something much more . While I agree long term will do OK, , but the truth would be nice. , but not expected tp be told.
Well, you got your answer. Did hurt, but is it a long term issue? Will the dollar continue to stay strong for an extended period? In any event, I added a bit here. Long term hold, great dividend payer. No worries long term.
Positive research article on new Abbott nutrition product (Ensure Enlive, in U.S.) was published today. Go to Abbott site and click on Headlines or Yahoo has it listed under their news. This formuation of Ensure was benefical in older malnourished adults. Product should be available in the US this year.